Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- C. M Gibson, MD
Beth Israel Deaconess Medical Center, The Baim Institute, and Harvard Medical School
Principal Investigator - Michael J Mack, MD
Baylor Scott & White The Heart Hospital
Principal Investigator - Richard Whitlock, MD
Hamilton General Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
29 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St. Boniface Hospital
Winnipeg, Manitoba, Canada
- Hamilton General Hospital, Hamilton Health Sciences Corporation
Hamilton, Ontario, Canada
- Kingston Health Sciences Centre
Kingston, Ontario, Canada
- London Health Sciences Centre, University Hospital
London, Ontario, Canada
- St. Michael'S Hospital, Unity Health Toronto
Toronto, Ontario, Canada
- Montreal Heart Institute
Montreal, Quebec, Canada
- Institut Universitaire de Cardiologie Et de Pneumologie de Québec - Université Laval
Québec, Quebec, Canada
- University of California, Davis Medical Center
Sacramento, California, United States
- Yale New Haven Hospital
New Haven, Connecticut, United States
- Medstar Health Research Institute
Washington D.C., District of Columbia, United States
- Emory University Hospital Midtown/emory School of Medicine
Atlanta, Georgia, United States
- Lutheran Medical Group
Fort Wayne, Indiana, United States
- University of Iowa
Iowa City, Iowa, United States
- University of Maryland Medical Center
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Mississippi
Jackson, Mississippi, United States
- Virtua Health
Marlton, New Jersey, United States
- Jersey Shore University Medical Center
Neptune City, New Jersey, United States
- New York University Langone Health
New York, New York, United States
- University Hospitals, Cleveland Medical Center
Cleveland, Ohio, United States
- Rhode Island Hospital
Providence, Rhode Island, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Baylor Scott & White the Heart Hospital Plano
Plano, Texas, United States
- University of Vermont Medical Center
Burlington, Vermont, United States
- Vcu Medical Center
Richmond, Virginia, United States
- Carilion Clinic
Roanoke, Virginia, United States
- University of Wisconsin-Madison
Madison, Wisconsin, United States
- the Medical College of Wisconsin, Inc.
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2021
- Primary completion
- 7 Aug 2023
- Completion
- 7 Aug 2023
- Last update posted
- 26 Oct 2026
- Registered enrollment
- 140
- Registry id
- NCT04976530
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.